Posaconazole
Product Images NDC 69367-248

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 69367-248). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Westminster Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Fig1)

Chemical structure of posaconazole displaying its multiple ring systems, including fluorinated aromatic rings, triazole groups, and hydroxyl and methyl substituents, consistent with its complex antifungal molecular framework.*

FDA Label Image

60-tab-label (Posaconazole 02)

POSACONAZOLE 100 mg delayed-release tablets label from Westminster Pharmaceuticals, LLC. The label states each tablet contains 100 mg posaconazole, includes storage instructions, and notes the tablets are not interchangeable with oral suspension. The package contains 60 tablets. Manufactured by Cohance Lifesciences Limited in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.